Investment Rating - The report indicates that the investment rating for the industry is positive, with forecasts for GDP growth in China significantly above consensus for 2025 and 2026 [4][5]. Core Insights - The report highlights an upward revision in GDP forecasts for China, driven by a strong manufacturing push, which is expected to enhance economic growth [5]. - The Global Financial Conditions Index (FCI) has shown a slight increase, indicating a more favorable financial environment for growth [9][32]. - Current Activity Indicators (CAI) for various regions, including China and India, reflect robust economic activity, with China reporting a CAI of +5.8% for September [54][56]. Summary by Sections GDP Forecast Changes - The report details changes in GDP forecasts for various regions, with notable increases for Taiwan (+1.9 percentage points) and Turkey (+1.2 percentage points) [6][12]. - The overall global GDP forecast has been adjusted positively, reflecting improved economic conditions across multiple countries [103][104]. Financial Conditions - The Global ex Russia FCI rose by +0.5 basis points over the week, suggesting a slight easing in financial conditions [9][32]. - The report provides insights into the implications of financial conditions on real GDP growth, indicating a positive correlation [45][46]. Current Activity Indicators - The CAI for the global economy stands at +2.7% for October, with developed markets at +1.5% and emerging markets at +4.5% [54][56]. - Specific countries like Spain and Australia show strong CAI values, indicating robust economic performance [54]. Wage and Price Inflation - Wage trackers indicate varying trends across different countries, with the US and Canada showing positive wage growth [73][75]. - The report discusses the impact of wage growth on inflation measures, highlighting the relationship between labor market conditions and price stability [21][22]. Fiscal Policy Impacts - The report analyzes the effects of fiscal policy on real GDP growth, with projections indicating a positive impact from expansionary fiscal measures in the US and other regions [84][89]. - It emphasizes the importance of fiscal impulses in shaping economic growth trajectories [87][90].

Investment Rating - The report indicates a positive outlook for the industry, with an upward adjustment in China's GDP forecast based on manufacturing investment growth expectations [1][5]. Core Insights - The easing of US-China trade tensions, including a 10% reduction in tariffs and postponement of certain regulations, is expected to mitigate trade friction in the short term, although long-term impacts remain uncertain [1][2]. - China's GDP forecast has been revised upward primarily due to anticipated growth in manufacturing investments, supported by the 15th Five-Year Plan's focus on advanced technology and manufacturing competitiveness [1][5]. - The Chinese government is likely to enhance monetary, fiscal, and credit policies to achieve an average growth target of 4.5% from 2026 to 2030, with a potential goal of around 5% set for 2026 [1][6]. Summary by Sections Trade Relations - Recent discussions between the US and Asian countries, particularly China, have led to a reduction in effective tariffs from over 100% to approximately 30%, with various port fees temporarily suspended [2]. - The trade agreements reached with Japan, South Korea, and Malaysia indicate a reduction in negative scenarios, although residual uncertainties remain [2]. Economic Growth Projections - The Asian economic growth outlook is moderate, with a shift from export-driven growth to reliance on domestic demand, necessitating more accommodative domestic policies [4]. - The low inflation levels in most countries provide room for monetary easing, with many expected to adopt such measures to support domestic demand growth [4]. Policy Adjustments - The Chinese government is expected to implement policies aimed at strengthening traditional industries and developing emerging sectors, focusing on both domestic consumption and international market expansion [3][10]. - The upcoming political meetings in December will be crucial for determining the direction of fiscal and monetary policies to support economic growth [12][13]. Currency Outlook - A moderate depreciation of the US dollar is anticipated due to potential Fed rate cuts and a significant fiscal deficit, while the Chinese yuan may experience gradual appreciation [3][9]. - The yuan's potential for appreciation is supported by its current undervaluation and the competitive nature of Chinese exports [9].

Investment Rating - The report does not explicitly provide an overall investment rating for the sectors discussed [2]. Core Insights - The technology sector experienced a positive month with the NDX closing near all-time highs, driven by AI-related themes and significant partnerships [3]. - Financials faced bearish narratives, particularly concerning regional bank credit and consumer credit, impacting investor sentiment [3]. - The healthcare sector saw improved sentiment due to drug pricing agreements and increased M&A activity, although some biopharma stocks reverted initial gains [3]. - Consumer sentiment has turned cautious, particularly in restaurants and grocery sectors, indicating potential slowdowns [3]. - Industrial stocks showed mixed performance, with data centers and AI-related companies gaining traction while materials underperformed [3]. - Energy sector discussions centered around negative oil views, with potential for volatility and price upside due to geopolitical factors [3]. - Utilities are focusing on EPS guidance updates, particularly related to data centers and power demand growth [3]. - Special situations saw increased M&A activity, with notable deals and strategic sponsor involvement [3]. Sector Summaries Technology - The sector saw a +5% increase in October, with AI themes driving performance [3]. - Key subsectors included Semiconductors (+11%) and Software, which remained flat [3]. Financials - The sector faced challenges with narratives around credit quality and consumer spending [3]. - Notable upcoming earnings reports from private credit firms are expected to provide insights [3]. Healthcare - The sector experienced a boost from drug pricing agreements and M&A activity, although some stocks faced volatility [3]. - Biotech sentiment improved following significant policy changes [8]. Consumer - Sentiment has shifted to a more guarded stance, particularly in restaurants and grocery sectors, indicating potential slowdowns [10]. - Upcoming earnings from major retailers will be critical to assess the impact of economic conditions [10]. Industrials - The sector showed modest gains, with data centers and AI-related stocks performing well [3]. - Concerns about inflation and earnings downgrades were noted in the materials subsector [3]. Energy - Investor sentiment remains cautious, with discussions around oil price volatility and geopolitical developments [3]. - The refining sector is experiencing mixed conversations regarding future expectations [3]. Utilities - Focus on EPS guidance updates and potential growth in power demand [3]. - M&A activity is expected to increase, with significant deals in the pipeline [3]. Special Situations - M&A activity surged in October, with notable deals and strategic sponsor involvement [3]. - The report highlights ongoing debates around valuations and potential acquisition targets [19].

Investment Rating - The report raises the 2025 real GDP growth forecast for China from 4.9% to 5.0% based on government spending acceleration and commitment to economic targets [6][10]. Core Insights - The report emphasizes the importance of China's manufacturing push in driving economic growth and highlights the expected annual growth of Chinese export volumes by 5-6% [9][10]. - It notes that the fiscal deficit is projected to widen by 1.0 percentage point of GDP in 2026, with total social financing stock growth expected to rise [9][10]. - The report discusses the ongoing focus on high-tech manufacturing and AI investment as a counterbalance to demographic and local government debt challenges [9][10]. Summary by Sections Current State of the Economy - The 2025 real GDP growth forecast has been raised to 5.0% due to increased government spending and commitment to economic targets [6]. 2026 Macro Views - The report anticipates a real GDP growth of 4.8% in 2026, which is significantly above market consensus [9]. - It expects the fiscal deficit to widen and further cuts in the reserve requirement ratio (RRR) and policy rates [9]. Medium- to Long-Term Views - Chinese export volumes are expected to grow by 5-6% annually, contributing to overall economic expansion [9]. - The report highlights the prioritization of manufacturing, technology, and security in China's 15th Five-Year Plan [9]. Economic Indicators - The report provides a detailed forecast of various economic indicators, including GDP growth, domestic demand, consumption, and inflation rates for the years 2025 to 2027 [13]. - It notes that household consumption is expected to grow at a rate of 4.6% in 2025, with government consumption at 4.0% [13]. Policy Measures - The report outlines several policy measures aimed at boosting consumption and investment, including a consumer goods trade-in program and increased government spending on infrastructure [81][82].

Jan Hatzius +1(212)902-0394 | jan.hatzius@gs.com Goldman Sachs & Co. LLC 30 October 2025 | 8:02AM EDT Economics Research GLOBAL ECONOMICS ANALYST AI Adoption Through the Eyes of GS Investment Bankers Joseph Briggs +1(212)902-2163 | joseph.briggs@gs.com Goldman Sachs & Co. LLC Sarah Dong +1(212)357-9741 | sarah.dong@gs.com Goldman Sachs & Co. LLC Megan Peters +44(20)7051-2058 | megan.l.peters@gs.com Goldman Sachs International Investors should consider this report as only a single factor in making their inve ...

Investment Rating - The report maintains a "BUY" rating for Pharmaron (3759.HK) since January 1, 2020, with a 12-month price target of HK$30.00, indicating an upside potential of 20.2% from the current price of HK$24.96 [1][12]. Core Insights - Pharmaron reported a 3Q25 revenue of Rmb3.65 billion, reflecting a year-over-year increase of 13.4% and a quarter-over-quarter increase of 9.1%, slightly exceeding Goldman Sachs estimates of Rmb3.48 billion. This growth was driven by strong performance in the CMC and bioscience segments, particularly from the top 20 large pharmaceutical clients [1][2]. - The management has raised the full-year revenue growth guidance to 12-16% year-over-year, up from the previous guidance of 10-15%, suggesting a potential growth of 6-20% year-over-year in 4Q25. The management is optimistic about further margin improvements in 4Q25 compared to the first nine months of 2025 [1][2]. - The report highlights robust new project order momentum, particularly in the CMC segment, where new project orders increased by 13% year-over-year for the first three quarters, with a notable 20% year-over-year rise in CMC new orders driven by large pharmaceutical demand [2][20]. Summary by Sections Earnings Review - 3Q25 revenue: Rmb3.65 billion, up 13.4% y/y and 9.1% q/q, slightly above GSe of Rmb3.48 billion [1]. - Non-IFRS adjusted net profit margin improved to 12.9%, up from 11.3% in 1Q25 and 12.2% in 2Q25, supported by higher utilization rates [1]. Revenue Growth and Guidance - Full-year revenue growth guidance raised to 12-16% y/y from 10-15% y/y, implying 4Q25 growth of 6-20% y/y [1]. - Continued investment in biologics and strategic acquisitions positions Pharmaron for sustained growth in the CDMO space [1][20]. Segment Performance - CMC revenue reached Rmb903 million, up 12.7% y/y and 29.6% q/q, with a gross margin of 34.6% [2]. - Clinical development revenue was Rmb501 million, up 8.2% y/y, but gross margin declined to 10.8% due to project mix and competitive pressures [3][19]. Strategic Acquisitions - The acquisition of Biortus is expected to enhance Pharmaron's biologics service offerings, particularly in structural biology data supporting drug discovery [20]. Financial Projections - Revenue projections for 2025E are Rmb14,066.7 million, with EBITDA of Rmb3,532.9 million and EPS of Rmb0.91 [6][17]. - The report anticipates a 3-year earnings CAGR of 15% [21].

Investment Rating - The report does not provide a specific investment rating for the industry Core Insights - The report emphasizes the importance of understanding technical analysis as a tool for investors, highlighting that price movements reflect supply and demand dynamics rather than underlying causes [17][18] - It discusses the psychological aspects of market behavior, noting that investor emotions can lead to irrational decision-making, which is a fundamental principle of technical analysis [17][21] - The report outlines various charting techniques and patterns that can be utilized to predict market movements, including trend lines, channels, and specific chart patterns like head and shoulders, triangles, and saucers [20][64][95] Summary by Sections Section I: Introduction - The introduction discusses the influence of behavioral finance on investor psychology and the role of technical analysis in capturing market trends [17][21] Section II: The Basics - This section covers the construction of different types of charts, including bar, candlestick, and line charts, and explains their significance in technical analysis [29][30] - It also introduces point and figure charts and market profile techniques, emphasizing their utility in identifying price movements and trends [31][35] Section III: Trend Lines and Channels - The report explains how to identify and draw trend lines, noting that trends can indicate support and resistance levels [44][48] - It discusses the significance of volume in confirming trends and the implications of trend line breaks [48][49] Section IV: Chart Patterns - This section categorizes chart patterns into reversal and continuation patterns, detailing how to identify and interpret them for trading decisions [64][95] - Specific patterns such as head and shoulders, double tops/bottoms, and triangles are described, along with their expected outcomes and volume behavior [74][95]

Investment Rating - The report maintains a "Buy" rating for CMOC Group (3993.HK) with a 12-month price target of HK$19.00, representing an upside of 17.3% from the current price of HK$16.20 [1][2]. Core Insights - CMOC reported a net profit of Rmb5.61 billion for 3Q25, reflecting a year-on-year increase of 96%, with earnings per share (EPS) rising to Rmb0.262, up 98% year-on-year [1]. - The recurring profit growth is expected to continue, driven by rising copper prices and volume growth, with a projected compound annual growth rate (CAGR) of 38% for 2025-26E [2]. - The company has revised its earnings estimates upward by 8-32% for 2025-27E, reflecting a positive outlook on copper prices and the impact of new cobalt export quotas from the DRC [2]. Financial Performance - For the first nine months of 2025, CMOC's recurring net profit reached Rmb14.1 billion, accounting for 75% of the full-year estimate [1]. - The company expects to achieve a copper output target of 1 million tons by 2028, supported by the Cangrejos gold/copper project, which is anticipated to further enhance earnings growth [2][29]. - The report indicates that CMOC's current H-share price implies a copper price of US$8,500/t, which is lower than the spot price of US$10,900/t, suggesting potential for price appreciation if targets are met [2]. Production and Operations - CMOC's copper output in the DRC reached 543kt in 9M25, a 14% increase year-on-year, while cobalt output was 88kt, up 3.8% year-on-year [26]. - The DRC government has introduced a cobalt export quota system, allowing CMOC to export 6.5kt for the remainder of 2025 and 31.2kt annually for 2026-27E, which is expected to improve gross profit for cobalt significantly despite lower sales volume [27]. - The acquisition of Lumina Gold for C$581 million is expected to enhance CMOC's net profit by 13.1% by 2030, with significant gold and copper reserves identified at the Cangrejos project [28]. Valuation Metrics - The report provides updated revenue and earnings estimates, with total revenue projected at Rmb213,028.7 million for 2024 and Rmb192,354.5 million for 2025E [6]. - The price-to-earnings (P/E) ratio is forecasted to be 9.2 for 2024 and 15.5 for 2025E, while the price-to-book (P/B) ratio is expected to be 1.8 for 2024 and 3.7 for 2025E [12]. - The report indicates a free cash flow yield of 19.6% for 2024, which is expected to decrease to 6.6% in subsequent years [12].

Investment Rating - The report indicates a bearish sentiment in the oil market, particularly with significant short positioning in Brent Crude [3][5]. Core Insights - Crude oil prices have surged following the announcement of sanctions on Russian oil giants by the Trump administration, raising questions about future price movements [1][13]. - Managed Money shorts in Brent Crude reached a 90% rank on a two-year lookback, indicating a strong bearish posture among traders [3][5]. - The report highlights that the recent price movements and trader behaviors suggest a potential for larger covering flows if the recent price increase holds [16][18]. Summary by Sections - **Market Reaction**: Following the sanctions on Russian oil producers, December Brent crude saw an intraday high increase of 5.5% on October 23rd, with significant movements in spreads and open interest [13][11]. - **Trader Positioning**: The Commitment of Traders data shows a substantial amount of Managed Money short positions, with a cumulative increase of $3.3 billion over four weeks [3][5]. - **Market Dynamics**: The report notes that the rolling six-month correlation between Managed Money spreads and front-term structure remains negative, indicating that shorts dominate the market [10]. Additionally, reports of India reducing purchases of Russian oil have contributed to market unease [10].

Investment Rating - The report indicates a cautious outlook on the retail sector amidst a choppy de-grossing market environment, suggesting that retail remains a dominant force despite the volatility [1][3]. Core Insights - Retail trading activity has surged, with retail investors accounting for over 16% of the total volume in S&P 500 stocks, marking a five-year high [7][9]. - The market is increasingly narrative-driven, with traders seeking compelling stories and catalysts to guide their investments [8][12]. - The volume of stocks executed by off-exchange venues, such as those serving retail platforms like Robinhood, is projected to reach 50% of total trading volume for the first time this year [9][12]. - Individual amateur investors are gravitating towards lightly regulated markets, with OTC Markets seeing an average monthly trading volume of approximately $59 billion, nearing the peak levels observed during the meme-stock frenzy [12][9]. - The report highlights a divergence in risk appetite, with retail investors remaining risk-seeking while institutional investors have adopted a more cautious stance [13][15]. Summary by Sections Trading Activity - On a recent trading day, 25.2 billion shares were traded across US equity exchanges, significantly above the year-to-date average of 17.2 billion shares [3][4]. - The top 10 stocks by trading volume accounted for approximately 8 billion shares, or 32% of the total market volume, with a majority being penny stocks favored by retail investors [4][7]. Market Sentiment - The current market sentiment is characterized by a high level of gross leverage and constrained net positions, indicating a cautious approach among institutional investors [22][23]. - The report notes that the unprofitable tech sector is experiencing a sharp correction, with some stocks, like Beyond Meat, showing significant reversals [28][29]. Earnings and Economic Indicators - Overall earnings remain supportive, but market reactions to earnings reports are becoming increasingly critical, as investors appear to be taking profits during the earnings season [29][31]. - The bond market has stabilized despite ongoing fiscal excess, with both nominal and real yields compressing at the long end, which is seen as bullish for equity multiples [33][34].